Bioventus (BVS) Assets Average (2021 - 2026)

Bioventus (BVS) has 6 years of Assets Average data on file, last reported at $667.0 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average fell 6.01% year-over-year to $667.0 million; the trailing twelve-month figure through Mar 2026 stood at $667.0 million (down 6.01% YoY), and the FY2025 full-year result was $705.8 million, down 8.28% from the prior year.
• Assets Average for Q1 2026 stood at $667.0 million, down from $692.6 million in the prior quarter.
• Across five years, Assets Average topped out at $1.4 billion in Q4 2022 and bottomed at $667.0 million in Q1 2026.
• The 5-year median for Assets Average is $802.6 million (2024), against an average of $901.7 million.
• The widest annual swing landed in 2022, when Assets Average surged 113.0%; it then tumbled 41.46% in 2023.
• A 5-year view of Assets Average shows it stood at $1.4 billion in 2022, then plunged by 41.46% to $811.0 million in 2023, then retreated by 7.68% to $748.7 million in 2024, then decreased by 7.5% to $692.6 million in 2025, then decreased by 3.69% to $667.0 million in 2026.
• The last three Assets Average figures came in at $667.0 million (Q1 2026), $692.6 million (Q4 2025), and $704.2 million (Q3 2025), per Business Quant data.

Peer Comparison